For those with type 2 diabetes, keeping blood sugar levels under control can seem like walking a tightrope. But that delicate balancing act may benefit more than just blood sugar.

Last year, new guidelines on treating high cholesterol placed a focus on overall risk instead of specific cholesterol levels. Those recommendations set off a debate in the medical community. The controversy rages on.

Deciding how to treat a condition like high cholesterol can be tough, especially when some treatment options have been tied to an increased risk of other health problems.

The FDA has approved Juvisync, a prescription medication that contains two previously approved medicines in one tablet: Januvia (sitagliptin) for diabetes and Zocor (simvastatin) for high cholesterol.